Point72 Asset Management’s Tectonic Therapeutic TECX Stock Holding History

Point72 Asset Management’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.12M	Sell	68,598 -423,734	-86%	-$10.4M	﹤0.01%	2269
2025 Q4	$10.3M	Buy	492,332 +70,577	+17%	+$1.31M	0.01%	1340
2025 Q3	$6.62M	Buy	421,755 +190,723	+83%	+$3.94M	0.01%	960
2025 Q2	$4.59M	Buy	231,032 +31,032	+16%	+$629K	0.01%	1006
2025 Q1	$3.54M	Buy	+200,000	New	+$6.52M	0.01%	1054
2023 Q2	–	Sell	-54,167	Closed	-$650K	–	2877
2023 Q1	$650K	Buy	+54,167	New	+$754K	﹤0.01%	1183
2022 Q1	–	Sell	-12,500	Closed	-$578K	–	1432
2021 Q4	$578K	Sell	12,500 -6,667	-35%	-$383K	﹤0.01%	958
2021 Q3	$1.28M	Sell	19,167 -23,750	-55%	-$1.95M	0.01%	830
2021 Q2	$4.58M	Buy	42,917 +9,484	+28%	+$1.12M	0.02%	622
2021 Q1	$5.09M	Buy	+33,433	New	+$5.44M	0.02%	564

Other funds holding TECX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Point72 Asset Management's TECX Position: Q1 2026 in Review

Point72 Asset Management reduced its Tectonic Therapeutic (TECX) stake by 86% in Q1 2026, selling an estimated $10.4M and leaving 68,598 shares worth $2.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2269.

Point72 Asset Management first reported a position in TECX in Q1 2021 and has held it in 10 quarters since. The position peaked at $10.3M in Q4 2025. 111 funds tracked by Wall St. Rank hold TECX as of Q1 2026.

Point72 Asset Management held 68,598 shares of Tectonic Therapeutic worth $2.12M as of Q1 2026.
Point72 Asset Management sold 423,734 Tectonic Therapeutic shares in Q1 2026, an estimated $10.4M.
Tectonic Therapeutic made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #2269 holding.
Point72 Asset Management first reported a position in Tectonic Therapeutic in Q1 2021 and has held it in 10 quarters since.
Point72 Asset Management's Tectonic Therapeutic position peaked at $10.3M in Q4 2025.
111 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.